• Users Online: 13576
  • Print this page
  • Email this page


 
 
Table of Contents
LETTER TO EDITOR
Year : 2021  |  Volume : 4  |  Issue : 3  |  Page : 571-572

Authors' reply to Pimple et al., Ghafur, and Potter


1 Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India
2 Department of Molecular Diagnostics, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India
3 Department of Infectious Diseases, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India

Date of Submission30-Aug-2021
Date of Decision30-Aug-2021
Date of Acceptance08-Sep-2021
Date of Web Publication08-Oct-2021

Correspondence Address:
Ullas Batra
Sector 5 Rohini, Sir Chhotu Ram Marg, New Delhi - 110 085
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/crst.crst_209_21

Get Permissions


How to cite this article:
Batra U, Nathany S, Sharma M, Bansal N. Authors' reply to Pimple et al., Ghafur, and Potter. Cancer Res Stat Treat 2021;4:571-2

How to cite this URL:
Batra U, Nathany S, Sharma M, Bansal N. Authors' reply to Pimple et al., Ghafur, and Potter. Cancer Res Stat Treat [serial online] 2021 [cited 2021 Dec 9];4:571-2. Available from: https://www.crstonline.com/text.asp?2021/4/3/571/327791



We thank Pimple et al.,[1] Ghafur,[2] and Potter[3] for their expert opinions on our article titled “COVID-19 vaccination status in Indian patients with cancer: An observational study.” The COVID-19 pandemic has ushered in a new era in the lives the general public, impacting the health-care fraternity the most.[4] Until the development of the vaccine, non-pharmaceutical measures including masking, social distancing, and nationwide lockdowns were employed to contain the disease,[5] however, most countries have exhibited a two-wave pattern of the pandemic in the last 2 years.

The vaccination drive in India is in full swing; however, due to lack of objective evidence from trials in patients with cancer, we experience hesitancy in this subgroup of our patients, who are at the highest risk of not only contracting the infection but also for related morbidity and mortality.[6.7] The two vaccines, Covaxin and Covishield, currently being administered in India have shown good results in preventing severe disease, as has also been highlighted in our experience. The main reason for hesitancy towards vaccination in this subgroup of patients as highlighted by Noronha et al.,[7] is fear. As oncologists, it is important that we teach and counsel our patients against this fear with the evidence generated through our experiences.

Although retrospective and single center in nature, ours[8] and a similar experience reported by Noronha et al.[7] have unearthed glaring disparities in this group. These are currently the only two studies from India highlighting the need to educate patients with cancer about the benefits of vaccination in the prevention of severe disease and for uninterrupted cancer-directed therapy.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Pimple S, Mishra G. Need for a national consortium of clinical registries of cancer and COVID-19 for vaccine surveillance. Cancer Res Stat Treat 2021;4:570-1.  Back to cited text no. 1
  [Full text]  
2.
Ghafur A. We need to tackle vaccine hesitancy in our patients with cancer. Cancer Res Stat Treat 2021;4:564-5.  Back to cited text no. 2
  [Full text]  
3.
Potter DA. The oncologist as COVID-19 vaccine teacher and logistician: A pathway to better outcomes. Cancer Res Stat Treat 2021;4:567-8.  Back to cited text no. 3
  [Full text]  
4.
Shrivastava SR, Shrivastava PS. Impact of the COVID-19 pandemic on patients with cancer and cancer survivors: A narrative review. Cancer Res Stat Treat 2021;4:315-20.  Back to cited text no. 4
  [Full text]  
5.
Kulkarni T, Sharma P, Pande P, Agrawal R, Rane S, Mahajan A. COVID-19: A review of protective measures. Cancer Res Stat Treat 2020;3:244-53.  Back to cited text no. 5
  [Full text]  
6.
Bansal N, Ghafur A. COVID-19 in oncology settings. Cancer Res Stat Treat 2020;3 Suppl S1:13-4.  Back to cited text no. 6
    
7.
Noronha V, Abraham G, Bondili SK, Rajpurohit A, Menon RP, Gattani S, et al. COVID-19 vaccine uptake and vaccine hesitancy in Indian patients with cancer: A questionnaire-based survey. Cancer Res Stat Treat 2021;4:211-8.  Back to cited text no. 7
  [Full text]  
8.
Batra U, Nathany S, Bansal N, Sharma M. COVID-19 vaccination status in Indian patients with cancer: An observational study. Cancer Res Stat Treat 2021;4:219-23.  Back to cited text no. 8
  [Full text]  




 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References

 Article Access Statistics
    Viewed110    
    Printed8    
    Emailed0    
    PDF Downloaded7    
    Comments [Add]    

Recommend this journal